FIELD: clinical immunology. SUBSTANCE: vaccine composition contains respiratory-syncytial virus proteins or their immunogenic fragments and adjuvants such as QS-21, 3-deacylated monophosphoryl lipid A, or their combinations. EFFECT: substantially increased humoral and cell- related immunogenicity of proteins. 11 cl, 3 dwg, 5 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THE MIXED VACCINE, A METHOD OF SIMULTANEOUS MIXED VACCINATION AND A METHOD OF IMMUNOGENICITY INCREASE | 1993 |
|
RU2121365C1 |
| RECOMBINANT VACCINE AGAINST VARICELLA ZOSTER VIRUS (VZV) | 2020 |
|
RU2772902C1 |
| F-PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS AND ITS USE | 2007 |
|
RU2464316C2 |
| RECOMBINANT CHIMERICAL nTBI POLYPEPTIDE-IMMUNOGEN WITH ABILITY TO INDUCE NEUTRALIZING ANTIBODIES TO TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS AND INTENDED FOR USE AS COMPONENT OF VACCINE AGAINST HIV-1 | 2016 |
|
RU2642258C1 |
| VACCINE AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR TRIGGERING IMMUNE RESPONSE | 2010 |
|
RU2585961C9 |
| HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | 2012 |
|
RU2681529C2 |
| RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS | 2012 |
|
RU2603732C2 |
| METHODS OF PRODUCING ADJUVANTED VIROSOME AND ADJUVANTED VIROSOMES, OBTAINED BY SAID METHODS | 2014 |
|
RU2694367C2 |
| VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2014 |
|
RU2723328C2 |
| FUSED PROTEINS OF CARCINOEMBRYONAL ANTIGEN | 2005 |
|
RU2380375C2 |
